Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovaza in patients with hypertriglyceridemia
NCT00934219Phase 4Unknown
- Sponsor
- The Jewish Hospital - Mercy Health
- Start
- Jul 2009
- Primary completion
- Jul 2012
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia, sponsored by The Jewish Hospital - Mercy Health. Primary endpoint: Triglycerides at 7 months. Status: unknown.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT00934219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934219.